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Abstract
Noninvasive approaches to measuring cerebral circulation and metabolism are crucial to furthering our understanding of
brain function. These approaches also have considerable potential for clinical use ‘‘at the bedside’’. However, a highly
nontrivial task and precondition if such methods are to be used routinely is the robust physiological interpretation of the
data. In this paper, we explore the ability of a previously developed model of brain circulation and metabolism to explain
and predict quantitatively the responses of physiological signals. The five signals all noninvasively-measured during
hypoxemia in healthy volunteers include four signals measured using near-infrared spectroscopy along with middle cerebral
artery blood flow measured using transcranial Doppler flowmetry. We show that optimising the model using partial data
from an individual can increase its predictive power thus aiding the interpretation of NIRS signals in individuals. At the same
time such optimisation can also help refine model parametrisation and provide confidence intervals on model parameters.
Discrepancies between model and data which persist despite model optimisation are used to flag up important questions
concerning the underlying physiology, and the reliability and physiological meaning of the signals.
Citation: Jelfs B, Banaji M, Tachtsidis I, Cooper CE, Elwell CE (2012) Modelling Noninvasively Measured Cerebral Signals during a Hypoxemia Challenge: Steps
towards Individualised Modelling. PLoS ONE 7(6): e38297. doi:10.1371/journal.pone.0038297
Editor: Jonathan A. Coles, Glasgow University, United Kingdom
Received March 15, 2012; Accepted May 2, 2012; Published June 5, 2012
Copyright:  2012 Jelfs et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The initial study was undertaken at University College London Hospitals and partially funded by the Department of Health’s National Institute for
Health Research Centres funding scheme. Subsequent research in this paper was funded in part by the Engineering and Physical Sciences Research Council grant
EP/D060982/1, Medical Research Council (MRC) grant G0701458 and Wellcome Trust grant WT/089914/A/09/Z. No additional external funding received for this
study and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bjelfs@medphys.ucl.ac.uk
Introduction
Improvements in noninvasive approaches for measuring cere-
bral circulation and metabolism have the potential to significantly
increase our understanding of the healthy and injured brain. Of
current interest is the use of near-infrared spectroscopy (NIRS) to
monitor simultaneously brain oxygenation, haemodynamics and
metabolism [1–4], particularly as part of a multimodal monitoring
strategy in neurointensive care [5]. In order to guide patient
management, the robust extraction of clinically relevant informa-
tion from these systems is key. However, interpretation of NIRS
and other measured signals requires both considerable knowledge
of the underlying physiology, and an understanding of the physics
of the measurement process itself. In situations such as these where
understanding in vivo physiology requires measurement whose
interpretation is itself dependent on an understanding of the
physiology we naturally require methodologies where modelling,
both of physiology and of the measurement process, play a key
role.
In this paper, the predictions of a previously developed model of
brain circulation and metabolism [6], termed BrainSignals, are
compared with experimentally measured data from ten healthy
volunteers each undergoing a series of three hypoxemic challenges
as described in [7]. BrainSignals itself was constructed and
parametrised primarily using published data, much of it from
in vitro experiments, and hence of a very different kind to the in vivo
measurements presented here. Thus one goal is to evaluate the
performance of BrainSignals in an in vivo context where there is
considerable physiological and measurement noise, and repeat-
able, controlled experiments are impossible. Preliminary studies
[8] suggested that in this context qualitative trends in certain
signals could be predicted with some consistency by the model.
Here, the aim is to carry out a more complete, quantitative,
comparison of data and model prediction, using both default and
optimised model parameters. This work should be seen in the
broad context of an iterative process of model development and
comparison to data gradually leading to convergence between
model predictions and measurements.
A key aspect if a model is ever to be used at the bedside in a
clinical context is that it must be able to inform not only on
averaged behaviour, but also on the behaviour of individuals who
will display a wide range of natural physiological and pathophys-
iological variation. The level of success of subject-specific
optimisations of physiology-based models, particularly those of
some complexity, is an important topic going beyond the specifics
of cerebral circulation and metabolism described here. Making a
model subject-specific involves reparametrisation in such a way as
to maximise its ability to describe the physiology of a particular
individual. In this context, success of the model is characterised via
its ability to reproduce data for an individual subject, given
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38297
available prior information/data on the subject. Here, the prior
information takes the form of a part of the experimental data-set
with the goal being to optimise the model using this data in such a
way as to improve the predictive capabilities of the model for the
rest of the data set. Hence the work presented here can be seen as
a step towards a more ambitious, longer-term aim of ‘‘subject-
specific’’ modelling. In particular our goals are:
1. To quantify the predictive capabilities of the model for each of
the different signals.
2. To find out to what extent model reparametrisation can
improve model predictions.
3. To determine the robustness with which physiologically
important model parameters can be determined for an
individual from data.
4. To identify systematic discrepancies between model predictions
and data and to speculate about the origins and resolutions of
these inconsistencies.
5. To generate testable hypotheses about how physiologically
important, but hard to measure, quantities might behave
during hypoxia.
However, it is important to clarify at the outset that we are
neither attempting to ‘‘validate’’ the model against the measure-
ments, nor to ‘‘validate’’ the measurement technologies with the
aid of the model.
Materials and Methods
Description of the Experiment
This study was approved by the Joint Research Ethics
Committee of the National Hospital for Neurology and Neuro-
surgery and the Institute of Neurology. The data analysed here is
from a study of 10 healthy subjects (7 male, 3 female, median age
32 years, range 30–39) for which all subjects gave written informed
consent. The details of the experimental protocols and measure-
ment methodologies are provided in previous publications [7,9].
In brief, inspired oxygen concentration (FiO2) was measured
using an inline gas analyser, and a pulse oximeter probe measured
arterial oxygen saturation (SaO2). The study commenced with five
minutes monitoring at normoxia. Then nitrogen was added to the
inspired gases with the aim of inducing a gradual fall in SaO2 to
approximately 80%; immediately after this was achieved, FiO2
was returned to normal for five minutes. This cycle was repeated
three times. Throughout the study, end tidal carbon dioxide
tension (EtCO2) and breathing rate were measured continuously
and fed back to subjects in order to adjust their minute ventilation
to maintain normocapnea. Heart rate and mean arterial blood
pressure (ABP) were also measured continuously.
A combination of two continuous wave near-infrared spectrom-
eters, an in-house developed broadband spectrometer (BBS)
previously described by Tisdall et al. [7], and the commercially
available NIRO 300 (Hamamatsu Photonics KK), were used in
conjunction with transcranial Doppler (TCD) ultrasonography to
monitor brain tissue haemodynamics, oxygenation and metabo-
lism [10]. Further details of the NIRS signals are given in the
following section. Mean velocity of blood (vMCA) was measured
in the basal right middle cerebral artery.
For the purposes of input to the model, and comparison with
model output, measured signals were preprocessed as follows: all
signals were visually inspected for well-characterised artifacts,
which, if present were manually removed; all signals were low pass
filtered to remove high frequency instrumentation and physiolog-
ical noise using a 5th order Butterworth filter with a cut-off
frequency of 0.1 Hz; all signals were resampled to 1 Hz; and linear
detrending was carried out on the differential spectroscopy signals.
From here on, the subjects will be referred to as Subject 1 to
Subject 10. The full set of three hypoxemic challenges carried out
on a subject will be termed an experiment, and a single
hypoxemic challenge will be referred to as a challenge. Thus 10
experiments each involving 3 challenges were carried out, giving a
total of 30 challenges. For the purposes of analysis, the division of
each experiment into three challenges was carried out manually by
choosing time-points in the middle of the periods of normoxia
between hypoxemic challenges, and cutting all data-sets at these
points.
Near-Infrared Spectroscopy
Four out of the five signals considered here are measured using
NIRS. Changes in tissue oxy- and deoxy-haemoglobin concen-
trations, termed DHbO2 and DHHb respectively, can be
measured using differential spectroscopy systems [11–13]. In the
analysis here, rather than directly using DHbO2 and DHHb, two
derived quantities, the total haemoglobin concentration change
DHbT~DHbO2zDHHb, and changes in the difference
DHbdiff~DHbO2{DHHb are used. The third signal under
consideration is the absolute tissue oxygen saturation (TOS),
which provides a percentage measure of mean oxygen saturation
across all vascular compartments in the region of tissue queried.
TOS has been used extensively as a marker of tissue oxygenation
in a range of applications [14–17] but its relationship to underlying
physiology is still under investigation [18–20]. Finally, in addition
to the haemoglobin chromophores, the CuA centre in cytochrome
c oxidase (CCO) is a significant NIR absorber. Changes in
oxidation of this centre give rise to the fourth NIRS signal
considered here, referred to as DoxCCO. Interpretation of the
physiological meaning of DoxCCO is, however, nontrivial. This
signal has been extensively investigated as a marker of cellular
oxygen metabolism [21–24], and a number of clinical studies have
been performed to elucidate its role as a measure of cerebral well
being [5,25,26]. Theoretical, qualitative analysis of how it
responds to changes in oxygenation, substrate supply, and
metabolic demand were carried out in [27], with more quantita-
tive discussion in [6].
The BrainSignals Model
The BrainSignals model is described in [6], and available for
download at [28]. This model is a simplification of the large scale
BRAINCIRC model in [29] and was constructed to aid prediction
of a number of measurable signals (including those described
above), thus allowing model performance to be better evaluated
against in vivo data and maximise the clinical relevance of the
previous modelling work. At the same time, model complexity was
minimised by removing or simplifying components of the
physiology regarded as nonessential to the basic observed
behaviours. This simplification resulted in a model consisting of
two components: a submodel of the cerebral circulation, which is
known to respond in complicated ways to a variety of stimuli [30],
and a submodel of mitochondrial metabolism related to those
presented in [31,32]. The two components are linked via the
processes of oxygen transport and consumption. Where possible,
model parameters were chosen to be consistent with thermody-
namic principles and in vitro data. Necessarily, a number of
parameters which were either expected to have wide physiological
variation between individuals or can be hard to measure were
given ‘‘typical’’ values, in the anticipation that they could be set via
more extensive comparison with in vivo data, as carried out here.
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Inputs and Outputs of the Model. Inputs to the Brain-
Signals model were three measured systemic signals: mean ABP,
SaO2 and EtCO2 (which was assumed to be equal to arterial
partial pressure of CO2, a model input parameter). Fig. 1 shows
typical input data for one subject (Subject 6). Note that the
experimental protocol meant that each hypoxemic episode was
neither necessarily of the same magnitude nor of the same
duration. Thus extrapolating from one hypoxemic challenge to the
next becomes nontrivial. Note further that a single challenge
cannot simply be treated as a drop in oxygen, as a number of other
systemic effects may be simultaneously occurring. These included
significant changes in mean blood pressure, and in some cases
significant changes in CO2 levels. These collateral effects were
extremely variable across the subject range. For example Subject 2
showed a rise in blood pressure during the experiment (Fig. 2, left),
while Subject 5, unlike Subject 6 shown in Fig. 1, did not show
significant CO2 drops during the hypoxemic challenges (Fig. 2,
right).
The four NIRS signals TOS, DoxCCO, DHbT and DHbdiff
along with vMCA were used to provide a comparison between
model and data. For the purposes of comparison between
measured and modelled signals, vMCA was scaled by an arbitrary
factor, which was chosen to equalise the average measured and
modelled signals in each case. The three differential spectroscopy
signals (DoxCCO, DHbT and DHbdiff) were subject to an
arbitrary baseline shift again chosen to equalise the average
signals. Measured and modelled TOS were compared without any
scaling or baseline shift.
In addition to predicting the above five signals, the model
produces a number of outputs which were not measured, and are
in general difficult to measure in clinical contexts, including the
levels of various chemical quantities in different compartments,
and perhaps most importantly cerebral metabolic rate for oxygen
(CMRO2). Model predictions of change in this quantity will be
detailed in the results. The full range of model variables and
outputs is described in [6].
Model optimisation. Carrying out model optimisation for a
number of data sets, as done here, is an important means of
identifying inadequacies of the model class, and problems with the
measurement process. An outline of the optimisation process is
presented in Fig. 3. Model optimisation broadly refers to
attempting to minimise the distance between a set of model-
predicted quantities and the corresponding measured quantities.
The compatibility of a measured data set with a particular set of
models (defined, for example, by free parameters in a model) is
quantified by the minimal distance achieved through the
optimisation process.
In this case to obtain the set of models for optimisation the
parameters which most affected the model predictions of the five
signals in question were determined through a dual approach.
Discussion with clinical collaborators was used to establish which
model quantities were potentially of most clinical use and also
which quantities might be expected to show widest physiological
variation. At the same time, a preliminary sensitivity analysis was
carried out on a large range of model parameters in different
scenarios. The seven optimisation parameters chosen through this
process were:
1. The normal venous-arterial volume ratio, VARn (i.e., 1/AVRn
in [6]). This can be expected both to vary from individual to
individual and to be sensitive to the particular placing of the
NIRS probes. Further, preliminary simulations showed that the
haemoglobin-related NIRS quantities were sensitive to the
values of this parameter.
2. Blood concentration of haemoglobin [Hb] (termed [Hbtot] in
[6]), which can also be thought of as representing haematocrit.
This is known to vary considerably between individuals. As
with AVRn, haemoglobin-related NIRS quantities showed
sensitivity to the values of this parameter.
3. A typical arteriolar radius rn. All haemodynamic model
quantities were sensitive to values of this parameter, and for
this reason it was included.
Figure 1. Typical input traces. SaO2 (%, top panel), mean ABP (mmHg, middle panel) and EtCO2 (mmHg, bottom panel) for a typical subject
(Subject 6) following the resampling and filtering described in the text. Each experiment lasted 30–40 minutes in total.
doi:10.1371/journal.pone.0038297.g001
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4. A dimensionless parameter u, representing normal energy
demand. All five outputs, including DoxCCO, showed
sensitivity to this parameter. However, preliminary simulations
gave ambiguous results about whether it could be reliably
determined from the data.
5. RO, the strength of cerebral blood flow (CBF) regulation in
response to arterial O2 levels. Given the potential clinical
importance of quantifying the regulatory response to changes
in O2 tension, we were keen to know whether this model
parameter could be determined consistently for an individual
from physiological data. Preliminary results were ambiguous,
so it was included.
6. RP, the strength of CBF autoregulation in response to changes
in blood pressure. Again, this is a quantity of potential clinical
importance. Although the challenge did not involve any
explicit manipulations of blood pressure, blood pressure often
showed considerable spontaneous natural fluctuation during
the challenge. Preliminary simulations suggested that this
model parameter could be determined with some accuracy for
an individual from physiological data.
7. tP, the typical time-constant for the pressure autoregulation
response. Preliminary investigation suggested that the flow
responses (as recorded by vMCA) did not show the delays
suggested by the literature on pressure autoregulation (e.g.
[33,34]). We wanted to find out if this was consistently the case.
Certain other parameters given initial consideration, for
example, the typical time-constant for autoregulatory response to
hypoxia, were found to be hard to determine from the data, and
hence were excluded. The computational methodology used a
simulated annealing approach using a simplex method, as
described in [34]. This choice was considered appropriate given
the large number of parameters being explored, the noisy nature
of the data, and consequent uncertainty about the smoothness of
the objective function. The initial temperature, the number of
temperature drops, and the stopping criteria were determined
heuristically. For the optimisations involving seven parameters and
all five output signals, a maximum of 10,000 steps were allowed.
When optimising for each signal individually a maximum of 1000
steps were allowed. All optimisations were run using the
BRAINCIRC modelling environment [36].
Table 1 shows the model default values, and the lowest and
highest values allowed by the optimisation process before a sliding
penalty was applied, all other model parameters were fixed at
default values. To avoid introducing undue bias into our results
the penalty applied was only a weak one, the reasons for applying
the penalty outside certain bounds were both to try to ensure
that the parameters remained within physiological ranges, and
also to ensure model stability. A graded penalty was applied to
avoid discontinuities in the objective function thus stabilising the
optimisation process.
Measuring the Success of the Optimisation Process
Comparing Model and Data. Given a particular signal, the
mean distance between the measured and modelled values of this
signal provides a quantification of the success of the model at
reproducing that signal (mean distances as opposed to the RMS
distances were chosen in order not to give undue weight to
outliers). More precisely, given a signal R, for subject s, during
challenge c, then ~d(R,s,c), is the unweighted mean of the absolute
difference between measured and modelled values of R during the
challenge (rescaled in the case of vMCA and with baseline shifted
in the case of the differential spectroscopy signals).
Figure 2. Examples of behaviour of the input signals. In both figures, arrows indicate the start of each hypoxemic challenge. Left. The mean
arterial blood pressure trace for Subject 2 showing a marked increase during the experiment. Right. The end tidal CO2 tension for Subject 5 was
maintained relatively constant across the hypoxemic challenges.
doi:10.1371/journal.pone.0038297.g002
Figure 3. Schematic of the model optimisation methodology.
Healthy subjects undergo a hypoxemic challenge, during which
systemic and cerebral data is gathered noninvasively. The systemic
data is fed into the physiological model, which then predicts expected
values of the cerebral signals. The difference between measured and
predicted values of these signals is used to construct an objective
function, and minimisation of this function is used to reparametrise the
model.
doi:10.1371/journal.pone.0038297.g003
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It should be noted that the difficulties involved in robustly
reproducing five signals simultaneously are considerably greater
than in reproducing one or two signals. For a given set of signals,
the weighted average of the distances across the signals provides a
measure of the success of the model at reproducing the signals
collectively. For two different signals R1 and R2 the distances
~d(R1,s,c) and ~d(R2,s,c) are not easily comparable as the signals
are measured in different units and have different typical values, or
typical changes during an experiment. In order to make the
quantities comparable, we define weights cR, and weighted
distances d(R,s,c)~cR
~d(R,s,c). The total distance between model
and data is then defined as a sum of the quantities d(R,s,c).
For each of the thirty challenges individually, an optimisation
was carried out to find the minimum achievable total distance
between the model and the data. From these preliminary
optimisations ~dmin(R), the smallest achievable values of ~d(R,s,c)
for each R and across a range of subjects and challenges could be
estimated. The weights cR were then chosen in such a way that
cR
~dmin(R) was similar for each of the five signals, for brevity this
set of optimisations is termed Fit 1. This methodology can be seen
both as normalising the signals, and also taking into account the
relative ability of the model to fit the signals individually.
Prediction factors. An important question is whether the
optimisation process improves the model’s ability to predict data
unseen by the optimisation. We are interested in whether for a
given subject and challenge, optimising the model for another
challenge from the same subject improves the model performance
compared to the unoptimised model. Let d(R,s,cD0) refer to the
scaled distance between model prediction and data for signal R,
subject s during challenge c, using the unoptimised model and
d(R,s,cD~c) refer to the corresponding distance following optimisa-
tion of the model for subject s, challenge ~c. So, for example,
d(R,1,1D2) would refer to the predicted distance in R for subject 1,
challenge 1, following optimisation for subject 1, challenge 2.
Then the percentage
P(R,s,cD~c):100
d(R,s,cD0){d(R,s,cD~c)
d(R,s,cD0)
,
provides a measure of the improvement in prediction of R for
subject s during challenge c given knowledge of challenge ~c.
P(R,s,cDc) can be regarded as a measure of the success of the
optimisation process for a particular signal. 100% represents
maximum improvement, that is an exact match between model-
prediction and data, post-optimisation, while values less than zero
represent a worsening of the prediction following optimisation
compared to predictions of the default model. This latter
possibility is not unrealistic: it can occur that in attempting to
find the best fit to all five quantities, the fit to some of the quantities
actually worsens. Hence the importance of appropriate choice of
the weights cR. For subject s and signal R we can compute the
quantity:
P(R,s)~
1
6
(P(R,s,1D2)zP(R,s,1D3)zP(R,s,2D1)
zP(R,s,2D3)zP(R,s,3D1)zP(R,s,3D2)):
P(R,s) will be termed a prediction factor. It quantifies the average
increase in predictability of signal R during a challenge on subject
s given knowledge of one other challenge for the same subject.
Results
Behaviour of the Unoptimised Model
Prior to discussing model optimisation and individualisation, it
is important to explore briefly the ability of the model with default
parameter values to reproduce the five signals. This was found to be
widely variable, both across subjects and across the different
signals with, however, some consistent trends. For illustrative
purposes we have chosen the individual challenges corresponding
to the best and worst fits pre-optimisation for each of the signals.
The results are shown in Fig. 4. The weighted distances from
model to data are also shown in each case.
Fig. 4 illustrates that even prior to optimisation the model
predictions were sometimes remarkably close to the data. However
there was considerable variation in this success, both across
subjects, and across signals. For example TOS showed many of
the worst initial fits as a consequence of the fact that its baseline
varies widely. Subject 10 showed some of the worst fits across a
range of signals. Each signal is examined in more detail in the
discussion.
Summary of Results of the Optimisation Process
Figure 4 shows the effect on the model performance of
optimisating each signal individually for those signals which
showed the best and worst performances prior to optimisation.
The signals for which the model had the best performances prior
to optimisation had on the whole only small improvement post
optimisation (and in some cases show small deterioration in
performance). The signals for which the model showed the worst
performance prior to optimisation highlight the level of variation
seen post optimisation, with some signals showing large improve-
ments (e.g. TOS) and others showing only small improvements
(DHbT). These results are illustrative of the range of results seen,
Table 2 shows the average values of d(R,:,:) for each of the signals,
across all of the challenges. The values in Table 2 can be
interpreted in the following way: the optimisation process makes
the most substantial difference to the signals TOS and DHbdiff .
Thus a mismatch between modelled and measured values of TOS
and DHbdiff may be at least partly attributable to the choice of
model parameters. On the other hand, the process does not
considerably improve DHbT, vMCA and DoxCCO.
In the case of the CCO signal, optimising this signal individually
gives a 12% improvement in fit, while the collective optimisation
causes an insignificant change. This should not be interpreted to
mean that the model was unsuccessful at predicting CCO: in fact
in 14/30 challenges d(DoxCCO,:,:) were less than 0.7 prior to
Table 1. Optimisation parameters.
Parameter Model default Penalty below Penalty above
VARn 3 1 5
[Hb] (mM) 9.1 5 12
rn (cm) 0.0187 0.012 0.022
u 1 0.1 4
Ro 1.5 0.1 8
Rp 4.0 0.5 10
tp (s) 5.0 0.5 10
Vext 0 0.0 0.7
The model defaults of the free parameters and lowest and highest values
permitted before the penalty was applied.
doi:10.1371/journal.pone.0038297.t001
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optimisation, which corresponds, given the low signal-to-noise
ratio of the CCO signal, to a reasonable fit. Rather, altering
parameters from the parameter set chosen does not appreciably
improve the DoxCCO fit on average.
For DHbT and vMCA, the outcome of the optimisation process
across challenges was very variable with maximum improvements
of 47% (DHbT) and 40% (vMCA), but also noticeable deterio-
ration in the fits for some subjects. The 28% and 33%
improvements following the respective single-signal optimisations,
compared to negligable improvements for collective optimisation,
suggests that there are difficulties associated with simultaneously
optimising the signals. It should be noted that DHbT changes were
on the whole considerably smaller than DHbdiff changes during
this challenge (see Fig. 4 for example), implying a greater signal-to-
noise ratio as both are derived from the same quantities and
measured in the same units. We return to these issues in the
discussion.
Improvement in Prediction Following Optimisation
We can term the process of optimising a model to partial data
from an individual model individualisation. The model
individualisation in this case involved optimising the model for
one challenge thus, allowing the remaining two challenges for that
experiment to be predicted. The success of model individualisation
is quantified by the prediction factors P(:,:). The prediction factors
for each signal, and for their weighted sum, are presented for each
subject in Table 3, showing that on average there is a considerable
improvement in the prediction of two signals, TOS and DHbdiff ,
Figure 4. Best and worst performance of the unoptimised model and optimisation results for each signal. Bold lines are the model
output post optimisation, grey lines are the unoptimised model output, while the dashed lines are measured data. The best fit prior to optimisation is
on the left, while the worst fit is on the right. The weighted distances d are on the bottom left of each plot, while the subject and challenge are on the
bottom right (e.g., ‘‘2(a)’’ means ‘‘Subject 2, first challenge’’).
doi:10.1371/journal.pone.0038297.g004
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following model individualisation. This is consistent with the
results obtained from optimising each challenge individually,
implying knowledge of the data during one challenge for an
individual improves the ability of the model to predict the
behaviour of these signals in subsequent challenges.
Predicting TOS Change during Hypoxia
Following analysis of the results of Fit 1, a systematic
discrepancy between modelled and measured TOS was identified.
While optimisation led to successful fitting of baseline TOS, the
model, both prior to and post optimisation, consistently overes-
timated the TOS drop during hypoxia. This occurred despite the
fact that arterio-venous volume ratio and haematocrit were free
parameters in the optimisation. The single-signal optimisations for
TOS were slightly better able to reproduce the observed signal (see
Table 2), but the systematic discrepancy remained. Thus it
appears that the comparatively low observed drops in TOS during
hypoxia were not compatible with the model variation allowed in
Fit 1.
In order to explore this discrepancy, a new quantity termed
TOSc, a corrected TOS defined as a weighted average between a
fixed default TOS and actual model-predicted TOS, was
constructed. One of the original set of seven free parameters (rn)
was replaced with the weighting used in the definition of TOSc,
termed Vext, and a second optimisation was carried out. This
second set of optimisations is termed Fit 2. Table 4 shows the
average values and % change of d(R,:,:) for Fit 2. This second
optimisation resulted in considerably better fits to the TOS data,
examples of the improvements observed are shown in Fig. 5 where
the distance between modelled and measured data is noticeably
decreased compared to Fit 1. When comparing the remaining
signals with Fit 1, vMCA and DHbdiff both show improvements
in the average results, DoxCCO shows no change and DHbT
shows that on average there is a slight decrease in the predictive
capabilities of the model. As with Fit 1 the results for DHbT were
still extremely variable with a maximum improvement of 35%.
To highlight the impact on model individualisation Table 5
presents the prediction factors for each signal, and their weighted
sum, for Fit 2. The overall values for Fit 2 are slightly better than
those for Fit 1, with an average improvement in prediction of
22.8% (Fit 1) and 24.6% (Fit 2). Moreover an improvement in
prediction of TOS after Fit 2, compared to Fit 1, occurred for
almost all subjects (see Tables 3 and 5), with very marked
improvement in some cases.
Robustness of Parameters Determined from Optimisation
One important question is whether certain clinically relevant
parameters, for example the strength of pressure autoregulation,
can be determined robustly via the optimisation process from data
of the kind presented here. Given some parameter X , the
following questions are relevant:
N How does the average value of X determined by optimisation
compare to the default values of X used in the model?
N What is the variation in X across the 30 challenges?
N What is the variation in X for an individual across the three
challenges?
Table 6 summarises the answers to these three questions
following Fit 1 and Fit 2 (model default values are given in
Table 1). Some parameters showed considerably wider variation
across the thirty challenges than others, quantified in the third and
sixth columns of Table 6. For example the standard deviation in
the optimal values obtained for u following Fit 1 was 68% of the
mean value. A large value like this may reflect different facts:
1. It is inherent in the physiological meaning of certain
parameters that model behaviour is sensitive to changes in
their values, for example they may occur squared or
exponentiated in certain model equations;
2. There can be naturally occurring differences in the amount of
physiological variability in certain quantities;
3. Some parameters may be hard to estimate from the data-set in
this study, and this is reflected in the high variability.
In order to distinguish between possibilities 2 and 3 above, it is
important to examine the difference between population standard
deviation as estimated from all 30 challenges (third and sixth
columns of Table 6) and the average population standard
deviation as estimated from each subset of three challenges on
an individual (fourth and seventh columns of Table 6). For every
Table 2. The (weighted) signal-to-data distances for each of
the five measured signals, and the sum of these distances,
averaged across all thirty challenges for Fit 1.
TOS vMCA DoxCCO DHbT DHbdiff
dtot(Fit
1)
Unoptimised: 1.87 0.60 0.81 1.11 1.10 5.47
Single-signal: 0.60 0.40 0.71 0.80 0.53 –
Fit 1: 0.70 0.55 0.78 1.02 0.66 3.72
Fit 1
(% improvement):
62% 8% 3% 7% 40% 32%
The first row contains these distances for the unoptimised model. The second
row shows the results following optimisation to each signal separately. These
numbers quantify the maximal ability of the model-class to reproduce the
signals individually. The third and fourth rows represent the distances and
percentage improvement following collective optimisation of the signals during
Fit 1. As we would expect, these distances are consistently higher than those
from the single-signal optimisations.
doi:10.1371/journal.pone.0038297.t002
Table 3. The prediction factors P(:,:) for each subject and
each signal following Fit 1.
Subject TOS vMCA DoxCCO DHbT DHbdiff dtot
1 20.3 24.9 24.2 2.9 36.2 17.1
2 76.0 28.4 211.3 19.9 57.7 48.9
3 215.5 23.3 2.3 216.0 22.7 3.0
4 32.2 6.7 20.1 28.2 47.0 15.0
5 10.9 11.9 4.9 2.0 7.1 6.5
6 65.1 214.9 22.0 12.0 38.6 37.5
7 39.3 6.1 26.6 11.8 32.4 20.6
8 3.3 3.7 20.1 3.9 20.1 6.1
9 50.4 229.8 20.1 10.8 50.5 29.1
10 81.3 10.3 22.2 27.3 28.3 44.0
average 36.3 0.4 21.1 3.2 34.1 22.8
The table is read as follows: consider the TOS entry for subject 4 (i.e., P(TOS,4))
which has value 32.2. This value means that the prediction of the value of TOS
for Subject 4 during some challenge was on average 32% improved by model
optimisation to data from a different challenge.
doi:10.1371/journal.pone.0038297.t003
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parameter and each optimisation, the latter is lower, suggesting
picking a model parameter X and estimating its value from data
for an individual, yields more clustered values than random choice
of this parameter from the distribution. This reassures us that
partial data from an individual can help us estimate each of the
parameters for an individual. It is consistent with the increased
predictability of signals from an individual following optimisation
using part of that individual’s data.
For the majority of the predicted parameters the average values
were reasonably close to their model default values, reflected in the
fact that entries in the second and fifth columns of Table 6 are
close to 1. However, for certain parameters the predicted averages
suggest values which whilst within the expected physiological limits
are further from the model defaults. In the case of tP, the data
consistently suggested values closer to 0.5 second, as opposed to
the default model value of 5 seconds. The blood concentration of
haemoglobin (haematocrit) [Hb], was also consistently lower than
model default of 9 mM and was on average closer to 5 mM. The
results also indicated a slightly stronger CBF response to arterial
O2 levels. The weighting Vext given to default model-predicted
TOS in Fit 2 can be seen as a damping factor, a damping factor of
0% would correspond to measured TOS responding as predicted
by the model, while 100% would correspond to completely
unresponsive TOS. The optimisation process resulted in an
average damping factor of 42+14%, illustrating the consistency of
the mismatch between model and data.
Model Prediction of Unmeasured Quantities: CMRO2
A key goal of the original modelling work was to create a model
capable of informing on the behaviour of quantities which are
hard to measure in clinical situations. One quantity which is both
hard to measure noninvasively and is of clinical importance is
CMRO2. According to the model moderate hypoxia, as carried
out here, resulted in a small but not negligible percentage drop in
CMRO2. The model predictions, prior to optimisation, were
remarkably consistent and were not appreciably altered by the
optimisation procedure. All thirty challenges resulted in small
percentage drops in CMRO2, the values of this percentage drop
were:
N Unoptimised model: 5.50 6 1.01 (range: 2.37% to 7.58%)
N Fit 1: 5.92 6 1.33(range: 2.11% to 9.49%)
N Fit 2: 5.73 6 1.10 (range: 2.27% to 9.34%)
The maximum change to the value of any particular drop as a
result of optimisation was small, with the majority of optimisations
having little effect on the model-predicted CMRO2 drop.
Figure 5. Error in predicted TOS during two challenges for Fit 1 and Fit 2. The TOS error is defined as TOS (model) - TOS (data). TOS error is
shown following Fit 1 (dashed line) and Fit 2 (bold line) for two example challenges (Subject 2, challenge 1 and Subject 8, challenge 2). The plots
illustrate that optimisation 2 considerably reduced the error in the prediction of TOS by reducing the expected drop in TOS during the hypoxemic
challenge.
doi:10.1371/journal.pone.0038297.g005
Table 4. The (weighted) signal-to-data distances for each of
the five measured signals, and the sum of these distances,
averaged across all thirty challenges for Fit 2.
TOSc vMCA DoxCCO DHbT DHbdiff dtot(Fit 2)
Unoptimised: 1.76 0.60 0.81 1.11 1.10 5.36
Fit 2: 0.44 0.50 0.78 1.13 0.63 3.48
Fit 2 (%change): 75% 17% 3% 22% 43% 35%
The first row contains these distances for the unoptimised model. The second
and third rows represent the distances and % change following collective
optimisation of the signals during Fit 2.
doi:10.1371/journal.pone.0038297.t004
Table 5. The prediction factors P(:,:) for each subject and
each signal following Fit 2.
subject TOSc vMCA DoxCCO DHbT DHbdiff dtot
1 8.5 213.7 3.7 4.3 38.9 14.7
2 82.6 26.2 213.3 225.8 62.1 46.2
3 214.7 23.3 2.2 220.0 26.6 4.0
4 28.1 21.2 2.2 210.1 52.2 16.8
5 43.4 7.0 2.8 29.6 11.6 13.1
6 70.0 7.4 20.4 29.2 50.0 38.7
7 50.9 27.6 21.9 9.3 23.6 22.9
8 3.6 6.3 20.2 0.8 25.9 7.6
9 66.4 11.4 22.1 20.3 51.3 34.2
10 89.2 20.4 1.3 210.1 29.0 47.9
average 42.8 7.0 20.6 27.1 37.1 24.6
Note that improvements in the prediction of TOS and DHbdiff were often
accompanied by a slight worsening of the prediction of DHbT.
doi:10.1371/journal.pone.0038297.t005
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Examples of SaO2 (measured) and CMRO2 (model predicted)
during an experiment are shown in Fig. 6. Discussion of this
prediction, and its relationship to the literature, can be found in
the concluding section.
Discussion
We have shown that the BrainSignals model has some success at
simultaneously reproducing qualitative and quantitative behaviour
of five measurable physiological signals during a hypoxemia
challenge. Further, model optimisation can be used to improve
model predictions for an individual. In this concluding section, we
first provide detail summarising the behaviour of the different
signals, as measured and as predicted by the model, and
highlighting any systematic discrepancies. We then explore some
possible origins of these discrepancies, and the extent to which
they could be resolved by altering model assumptions. Finally, the
optimisation process itself is examined in order to draw
conclusions about model parametrisation.
Behaviour of the Measured and Modelled Signals
A number of open questions exist in the literature about the
reliability, reproducibility, and interpretation of NIRS signals in
the context of various physiological challenges (see references in
the introduction). Provided some caution is exercised, there is the
potential for model-based approaches to inform on these debates.
Below, comments on each of the five measured signals are
presented and the question of how model-predicted changes in
CMRO2 relate to previous observations in the literature, is briefly
discussed.
DoxCCO. This is probably the signal with the lowest signal-
to-noise ratio, and also the signal which is hardest to interpret
physiologically. In this context, the unoptimised model was
relatively successful at reproducing the observed signal. However
the optimisation process did not greatly reduce the model-to-data
distance, either when carried out on the signal in isolation, or in
combination. For certain individuals, the signal prior to detrending
shows drifts and/or large fluctuations (in the region of 1 mM or
more) which are not reflected in the other signals (data not shown),
and it is possible that the signal processing carried out here is
insufficient to allow robust quantitative analysis when this is the
case. Interestingly, it is fairly easy to identify, without reference to
the model, experiments where the DoxCCO signal appears to be
inconsistent with physiological expectations.
vMCA. Inspection of the data suggests that this signal is fairly
consistent with model predictions both before and after optimi-
sation. While the optimisation process did not cause a large
improvement in the match between the modelled and measured
data, this can be at least partly attributed to the fact that the model
generally successfully predicted changes in vMCA even before
optimisation. Unlike previous modelling work [29,33], the
BrainSignals model ignored possible changes in middle cerebral
artery diameter during dilation. The data from the present study
broadly justifies this choice.
TOS. This was the signal to which optimisation made the
biggest difference, primarily because baseline TOS varied widely.
On the other hand the model, both before and after optimisation,
could not account for the comparatively small drops in TOS
observed during hypoxia. The heuristic assumption that observed
TOS changes were ‘‘damped’’ (Fit 2) led to a considerable
Table 6. Values of the free model parameters following
optimisation.
Fit 1 Fit 2
X X (+s(X )) s(X )=X s(Xi)=Xi X (+s(X )) s(X )=X s(Xi)=Xi
VARn 0.93(60.39) 0.42 0.27 0.94(60.34) 0.37 0.16
[Hb] 0.58(60.17) 0.30 0.15 0.59(60.15) 0.25 0.10
rn 0.92(60.14) 0.15 0.11 – – –
u 1.09(60.75) 0.68 0.45 0.87(60.55) 0.64 0.43
Ro 1.90(60.99) 0.52 0.34 1.17(60.67) 0.57 0.40
Rp 1.15(60.42) 0.36 0.20 1.21(60.30) 0.25 0.14
tp 0.13(60.13) 0.97 0.48 0.14(60.10) 0.69 0.56
Vext – – – 0.42(60.14) 0.33 0.25
X represents the mean value of parameter X across all thirty challenges. In all
cases except Vext , the value is divided by the default parameter value. Thus a
value close to 1 implies that the model default is consistent with the data from
the study. s(X ) is the population standard deviation of values of X across all
thirty challenges. A low value of s(X )=X implies that parameter X does not
show great variation between subjects. Xi represents the mean value of
parameter X across the three challenges for individual i (normalised, except for
Vext). s(Xi) represents the population standard deviation of values of X across
all three challenges for individual i. Low values of s(Xi)=Xi suggest that a
parameter can be reliably determined for an individual.
doi:10.1371/journal.pone.0038297.t006
Figure 6. Two examples of measured SaO2 and model-predicted CMRO2 during an experiment. The model predictions are without
optimisation. In each case the dashed line is SaO2 as a ratio, while the bold line is CMRO2 normalised to its initial value. Left. Subject 1. This is a fairly
typical trace. Right. Subject 5. Both SaO2 and CMRO2 are more variable, but again the model predicts that CMRO2 changes follow the trends in
SaO2 .
doi:10.1371/journal.pone.0038297.g006
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improvement in fit. This is discussed further in the following
section.
DHbdiff. This was another signal which even prior to
optimisation had a reasonable match between measured and
modelled values. It was also the signal to which the optimisation
process made the second largest difference. The worst fit shown in
Fig. 4 is not consistent behaviour and appears to be more related
to the time-course of the DHbdiff drop during the hypoxemic
challenge than its magnitude. As a difference between two
measured signals (DHbO2 and DHHb) it is possible that some
correlated measurement errors cancel, leading to an improved
signal-to-noise ratio.
DHbT. This signal was of fairly small magnitude, consistent
with the the relatively small increase in vMCA, and suggesting that
vascular dilation caused by hypoxia of this magnitude does not
cause large blood volume changes. The relatively large (weighted)
model-to-data distance for some subjects may be partly explained
by small absolute changes in DHbT. However this may not be the
whole story: when optimised singly, model and data could be
better matched than when the optimisation included all signals.
This suggests that there may be confounding physiological (as
opposed to measurement) effects.
DCMRO2. This was not directly measured, but, as mentioned
previously, the model was quite consistent in its prediction that
drops in SaO2 of the order of 15–20% should lead to small but not
negligible drops in CMRO2. Ref. [37] suggests that while severe
hypoxia causes significant decreases in CMRO2, moderate
hypoxia in the range considered here does not alter CMRO2.
On the other hand, it is worth noting that a drop of a few percent
is within the margins of error in the data in [37]. Moreover, the
challenges were carried out in anaesthetised dogs, where the
average CBF increase observed (150%) during the moderate
hypoxia considerably exceeds the average CBF increase inferred
from the vMCA data in our study, possibly compensating for the
drop in oxygen tension. The data for anaesthetised and awake rats
in [38] is similarly inconclusive, suggesting that hypoxia in the
range considered here caused significant decreases in CMRO2
under anaesthetised conditions but not under awake conditions.
Again, it is not clear whether changes in CMRO2 in the 5% range
could be reliably estimated by the biophysical BOLD model in
question. In sum, it remains an open question whether moderate
hypoxia causes a small, but non-negligible, change in CMRO2.
Explaining Systematic Discrepancies between Model and
Data
The compatibility of a data-set with a model class is represented
by the ability of a model to reproduce the data-set following
optimisation. When optimisation cannot adequately reproduce a
data-set, there may be conceptually distinct explanations:
N Incompleteness of the physiological model class: certain
physiological effects are missing from the model, or alterna-
tively, the parameter set chosen for optimisation does not allow
sufficient room to obtain the observed behaviours.
N Signal misrepresentation in the physiological model: the
physiological interpretation of certain signals is incorrect or
incomplete. For example, the two-compartment characterisa-
tion of TOS as the weighted sum of arterial and venous
haemoglobin saturation, may be too simplistic.
N Signal misinterpretation in the measurement model: the
modelling of the measurement process external to the
physiological model may be incomplete or flawed, leading,
for example, to incorrect translations of raw NIRS data into
concentrations or concentration changes.
With these broad principles in mind, we focus in on the most
marked and consistent discrepancy between model predictions and
data, which concerned the behaviour of TOS during hypoxia. The
origin of the discrepancy between model predicted TOS and
observed TOS remains unclear, and given the reproducibility of
the TOS signal is perhaps the most important discrepancy to
explain. Based only on the definition of TOS, it is possible to gain
some insight into why model-predictions for TOS drops during
hypoxia exceed the observed drops. Indeed, a simple interpreta-
tion of TOS as a weighted sum of arterial and venous saturations
allows calculation of the approximate changes in TOS which
might be observed during hypoxia. Define SvO2 to be mean
venous oxygen saturation, and
TOS~
AVR SaO2zSvO2
1zAVR
:
Assume initially SaO2~96% and SvO2~62% and AVR~1=3,
giving TOS~70:5%. Given an SaO2 change, by simple conser-
vation of O2, the ratio of initial to final CMRO2 is simply the ratio
of initial to final CBF multiplied by the ratio of initial to final
arterio-venous saturation difference. For example, assume that a
drop in SaO2 down to 80% occurs, which leads to a 5% drop in
CMRO2, a 10% increase in CBF (as seen approximately in the
vMCA data), and a 15% increase in AVR due to arterial dilation.
This results in SvO2 dropping to approximately 48% and TOS to
about 57%. This 13–14% predicted drop compares with a 7–8%
drop actually observed in the data. An explanation based on
physiology is possible, but requires one or more of:
1. CMRO2 drops to be greater than predicted;
2. CBF changes to be larger than reflected in the vMCA changes;
3. Arterio-venous volume ratio changes during hypoxia to be
considerably larger than predicted.
Each of these possibilities is hard to justify. Further, the damped
response of TOS is consistent with preliminary studies on the
simultaneous response of TOS and vMCA to changes in inspired
CO2 levels [39]. In this case, increased CO2 causes significant
increases in vMCA, and hence presumably in CBF, which are not
visible to the expected degree in the TOS signal.
Conclusions about Model, Physiology and
Pathophysiology
Several of the difficulties inherent in pursuing clinically-directed
modelling work have been previously described [40]. Of these, the
most pressing involves setting the boundaries of the model class,
that is choosing what physiology to include in the model and
defining ‘‘tolerances’’ for the values of model parameters. To this
end the range of behaviours associated with healthy physiology are
examined to ultimately inform on pathophysiology. In this study,
we have made progress in these directions, in particular towards
finding average values and ranges of variation of model
parameters consistent with measured data from healthy volun-
teers. Progress has also been made towards identifying and
explaining areas of discrepancy between model and data.
Model Parametrisation. In some cases the optimisations
suggest that model default values of certain parameters need to
be corrected. For example, the expected delay in the CBF
response to blood pressure changes is not observed in NIRS or
TCD data, suggesting short-timescale autoregulatory processes,
perhaps superimposed on the slower ones. The model optimi-
sations also indicate a lower default haematocrit. Measurements
taken from each of the subjects prior to the start of the study
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gave an average blood concentration of haemoglobin of
9:05(+0:6)mM which is in line with the model default of
9.1 mM. The average value post optimisation of 5.27 mM may
at least in part be attributed to the differences between venous
and cerebral haematocrit. Studies have consistently reported
cerebral haematocrit as lower than peripheral venous haemato-
crit [41,42] suggesting the need for a change in the model default
value. The exact relationship between venous and cerebral
haematocrit is not however, straightforward [42] and further
analysis is required to determine by what magnitude this
parameter should be reduced. Similarly, the optimisations suggest
somewhat stronger regulatory response to arterial O2 levels than
previous model default values. Of course, given the small number
of individuals in the study such suggestions about average values
need to be treated cautiously. Nevertheless, they provide
suggestions for improvements to model parametrisation.
Confidence in Model Parameter Values. The values
determined by optimisation provide some insight into the potential
variability to be expected in model parameters. For example, the
results on haematocrit tell us that variations of the order of+30%
around the default value (Table 6) are consistent with haemoglo-
bin-related NIRS data from this study. On the other hand
variability in the predictions for a single subject are +15%,
suggesting that some of the +30% variation can be attributed to
genuine inter-subject variability, as opposed to, say, measurement
noise. The same general conclusion is true for the other
parameters.
Information of Clinical Relevance. An important question
is what meanings can be ascribed to parameter values obtained for
an individual from the optimisation process. For example, even
though this study did not explicitly involve blood pressure
manipulations, it is instructive to ask what conclusions can be
drawn from this data about a subject’s ability to regulate CBF in
response to hypoxia and changes in blood pressure. The rows
relating to the quantities RO and RP in Table 6 provide an answer
to this question. The lower intra-individual variation compared to
the total group variation of RP is marked, suggesting in theory, we
can distinguish between subjects with a weak or strong CBF
response to pressure changes. The results of CBF regulation in
response to blood gas changes were less robust. The variation in
values for RO was considerably larger than that in values of RP.
This indicates that extracting reliable estimates of RO for an
individual is a harder task than extracting reliable values of RP.
This may also reflect the fact that each rapid fluctuation in blood
pressure provides data to estimate RP, whereas each challenge
involves essentially a single drop in SaO2, and thus the effective
volume of data from which RO is being estimated is much less. An
interesting question is whether inter-subject variability in these
quantities may have clinical significance, a question which can
only be answered in the context of applying the same method-
ologies to pathophysiological data.
Final Comments
The results suggest we can draw conclusions about the
methodology which go beyond the BrainSignals model. We have
shown that attempting to simultaneously interpret a number of
signals with the aid of a physiological model is a challenging task,
but with considerable potential reward, particularly in providing
clinically relevant information at the bedside to aid patient
management. Despite a variety of limitations and difficulties, we
can conclude that tackling a large problem (here, optimising seven
free parameters using data from five measured signals) is not
unfeasibly ambitious. At the very least, via this process, it is
possible to increase the predictive capabilities of a model for an
individual. Perhaps more importantly, the optimal parameter
values may themselves provide clinically useful information.
Regarded collectively, exploration of this kind can provide a
handle on the range of variability in model parameters consistent
with data from healthy volunteers, a crucial precondition for
further study in pathophysiological situations.
Several natural next steps exist, building on this work. One
question is whether applying the same methodologies to data
obtained from other challenges, for example during hypercapnia,
or during blood pressure manipulation, gives conclusions consis-
tent with those from this study. Another question is what we
discover if the same techniques are applied to pathophysiological
data.
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